See the Full Picture.
Published loading...Updated

NEC: Harnessing Artificial Intelligence-Powered Drug Development to Provide Tailored Medicines

Summary by Nature
Individualized cancer therapies represent the next step for cancer immunotherapy. NEC Corporation has developed cutting-edge artificial intelligence to predict patient-specific neoantigens to turn this promise into reality and extend the approach to infectious diseases.

4 Articles

All
Left
Center
2
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Friday, May 16, 2025.
Sources are mostly out of (0)